Suppr超能文献

Toll 样受体 9 激活介导的加速伤口愈合。

Accelerated wound healing mediated by activation of Toll-like receptor 9.

机构信息

Cancer and Inflammation Program, National Cancer Institute, Frederick, Maryland 21702, USA.

出版信息

Wound Repair Regen. 2010 Nov-Dec;18(6):586-93. doi: 10.1111/j.1524-475X.2010.00632.x. Epub 2010 Oct 13.

Abstract

Wound healing is mediated through complex interactions between circulating immune cells and local epithelial and endothelial cells. Elements of the innate immune system are triggered when Toll-like receptors (TLR) are stimulated by their cognate ligands, and previous studies suggest that such interactions can accelerate wound healing. This work examines the effect of treating excisional skin biopsies with immunostimulatory CpG oligodeoxynucleotides (ODN) that trigger via TLR9. Results indicate that CpG (but not control) ODN accelerate wound closure and reduce the total wound area exposed over time by >40% (p<0.01). TLR9 knockout mice, a strain unresponsive to the immunomodulatory effects of CpG stimulation, are unresponsive to ODN treatment and exhibit a general delay in healing when compared with wild-type mice. CpG ODN administration promoted the influx of macrophages to the wound site and increased the production of vascular endothelial growth factor, expediting neovascularization of the wound bed (p<0.01 for both parameters). Stimulation via TLR9 thus represents a novel strategy to accelerate wound healing.

摘要

伤口愈合是通过循环免疫细胞与局部上皮细胞和内皮细胞之间的复杂相互作用来介导的。当 Toll 样受体 (TLR) 被其同源配体刺激时,先天免疫系统的元素被触发,先前的研究表明这种相互作用可以加速伤口愈合。这项工作研究了用免疫刺激 CpG 寡脱氧核苷酸 (ODN) 治疗切皮活检的效果,这些 ODN 通过 TLR9 触发。结果表明,CpG(而非对照)ODN 可加速伤口闭合,并随着时间的推移减少暴露的总伤口面积>40%(p<0.01)。TLR9 敲除小鼠对 CpG 刺激的免疫调节作用无反应,对 ODN 治疗无反应,与野生型小鼠相比,愈合普遍延迟。CpG ODN 给药促进了巨噬细胞向伤口部位的浸润,并增加了血管内皮生长因子的产生,加速了伤口床的新血管生成(两个参数均 p<0.01)。因此,通过 TLR9 刺激代表了一种加速伤口愈合的新策略。

相似文献

1
Accelerated wound healing mediated by activation of Toll-like receptor 9.
Wound Repair Regen. 2010 Nov-Dec;18(6):586-93. doi: 10.1111/j.1524-475X.2010.00632.x. Epub 2010 Oct 13.
2
The acceleration of wound healing in primates by the local administration of immunostimulatory CpG oligonucleotides.
Biomaterials. 2011 Jun;32(18):4238-42. doi: 10.1016/j.biomaterials.2011.02.043. Epub 2011 Mar 21.
3
Effects of systemic pretreatment with CpG oligodeoxynucleotides on skin wound healing in mice.
Wound Repair Regen. 2013 Sep-Oct;21(5):723-9. doi: 10.1111/wrr.12084. Epub 2013 Aug 8.
4
Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
Front Immunol. 2019 Feb 8;10:179. doi: 10.3389/fimmu.2019.00179. eCollection 2019.
5
TLR9 ligand CpG-ODN applied to the injured mouse cornea elicits retinal inflammation.
Am J Pathol. 2012 Jan;180(1):209-20. doi: 10.1016/j.ajpath.2011.09.041. Epub 2011 Nov 12.
7
Impact of modifications of heterocyclic bases in CpG dinucleotides on their immune-modulatory activity.
J Leukoc Biol. 2004 Sep;76(3):585-93. doi: 10.1189/jlb.0104034. Epub 2004 Jun 24.
10
Expression of Toll-like receptor 9 and response to bacterial CpG oligodeoxynucleotides in human intestinal epithelium.
Clin Exp Immunol. 2005 Aug;141(2):298-306. doi: 10.1111/j.1365-2249.2005.02848.x.

引用本文的文献

3
Immunoengineering strategies to enhance vascularization and tissue regeneration.
Adv Drug Deliv Rev. 2022 May;184:114233. doi: 10.1016/j.addr.2022.114233. Epub 2022 Mar 15.
5
IL-10 Dysregulation Underlies Chemokine Insufficiency, Delayed Macrophage Response, and Impaired Healing in Diabetic Wounds.
J Invest Dermatol. 2022 Mar;142(3 Pt A):692-704.e14. doi: 10.1016/j.jid.2021.08.428. Epub 2021 Sep 10.
7
The Dichotomous Responses Driven by β-Defensins.
Front Immunol. 2020 Jun 12;11:1176. doi: 10.3389/fimmu.2020.01176. eCollection 2020.
8
EFFECT OF PROBIOTIC ORAL ADMINISTRATION ON SKIN WOUND HEALING IN RATS.
Arq Bras Cir Dig. 2019 Dec 9;32(3):e1457. doi: 10.1590/0102-672020190001e1457. eCollection 2019.
9
Cooperation of Oligodeoxynucleotides and Synthetic Molecules as Enhanced Immune Modulators.
Front Nutr. 2019 Aug 27;6:140. doi: 10.3389/fnut.2019.00140. eCollection 2019.
10
Activation of Toll-Like Receptor 9 Impairs Blood Flow Recovery After Hind-Limb Ischemia.
Front Cardiovasc Med. 2018 Oct 16;5:144. doi: 10.3389/fcvm.2018.00144. eCollection 2018.

本文引用的文献

1
Marked enhancement of the immune response to BioThrax® (Anthrax Vaccine Adsorbed) by the TLR9 agonist CPG 7909 in healthy volunteers.
Vaccine. 2011 Aug 26;29(37):6313-20. doi: 10.1016/j.vaccine.2011.05.047. Epub 2011 May 30.
2
A suppressive oligodeoxynucleotide inhibits ocular inflammation.
Clin Exp Immunol. 2009 Jun;156(3):528-34. doi: 10.1111/j.1365-2249.2009.03918.x.
3
Immunotherapeutic applications of CpG oligodeoxynucleotide TLR9 agonists.
Adv Drug Deliv Rev. 2009 Mar 28;61(3):195-204. doi: 10.1016/j.addr.2008.12.008. Epub 2009 Jan 13.
5
Effect of CpG oligonucleotides on vaccine-induced B cell memory.
J Immunol. 2008 Oct 15;181(8):5785-90. doi: 10.4049/jimmunol.181.8.5785.
7
Suppressive oligodeoxynucleotides inhibit silica-induced pulmonary inflammation.
J Immunol. 2008 Jun 1;180(11):7648-54. doi: 10.4049/jimmunol.180.11.7648.
9
Wound healing is impaired in MyD88-deficient mice: a role for MyD88 in the regulation of wound healing by adenosine A2A receptors.
Am J Pathol. 2007 Dec;171(6):1774-88. doi: 10.2353/ajpath.2007.061048. Epub 2007 Nov 1.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验